Company / Current Assets per Share
Corcept Therapeutics Incorporated Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$4.62
FY2025
5-year range
$2.28 / $4.71
FY2021-FY2025
Trend
+1.3%
vs FY2024
Sector context
#139 of 210
Health Care
What the data says
At $4.62, Corcept Therapeutics Incorporated's current assets per share ranks #139 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $0.60 in FY2016 to $4.71 in FY2022.
Based on SEC 10-K filings.
4.62 in FY2025 with a 5-year CAGR of +2.0%.
Improved from $4.25 to $4.62 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -0.7%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Sector benchmark
#139 of 210 in Health CareTop 66% of 210This company $4.62 Sector average $134.38
▼
-96.6% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 1.3% year-over-year.
- Ranks #139 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2022.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.62 | +1.3% |
| FY2024 | $4.56 | +7.2% |
| FY2023 | $4.25 | -9.7% |
| FY2022 | $4.71 | +106.5% |
| FY2021 | $2.28 | -45.4% |
| FY2020 | $4.18 | +56.3% |
| FY2019 | $2.67 | +29.4% |
| FY2018 | $2.06 | +87.4% |
| FY2017 | $1.10 | +83.9% |
| FY2016 | $0.60 | +24.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026